Outcome of patients with rheumatoid arthritis treated by step-wise administration of disease-modifying antirheumatic drugs over a 10-year period

Modern Rheumatology

Volumn 13, Issue 1, 2003, Pages 27-34

  Hamada, Yoshiaki ^a   Shinomiya, Fumio ^a   Okada, Masahiko ^a   Fujimura, Takuya ^a  

^a Tokushima Kensei Hospital   (Japan)

Author keywords

Disease activity; Disease modifying antirheumatic drug (DMARDs); Long term outcome; Step wise administration; X ray finding

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AUROTHIOMALATE; BUCILLAMINE; C REACTIVE PROTEIN; GOLD DERIVATIVE; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ARTICLE; BONE MARROW SUPPRESSION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HIP; HUMAN; INFLAMMATION; JOINT DESTRUCTION; KIDNEY DYSFUNCTION; KNEE; LIVER INJURY; LUNG DISEASE; MALE; OUTCOMES RESEARCH; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; PRURITUS; QUALITY OF LIFE; RADIODIAGNOSIS; RASH; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SIDE EFFECT; STOMATITIS; TASTE DISORDER; WRIST RADIOGRAPHY;

EID: 0043175083     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101650300004     Document Type: Article

References (20)

1. Shinomiya F, Hamada Y. Outcome of step-wise use of DMARDs in patients with early rheumatoid arthritis. Clinical efficacy of DMARD therapy in delaying the progression of multiple joint destruction (in Japanese). Igaku no Ayumi 1998;186:149-53.
2. Shinomiya F, Hamada Y. Long-term results of DMARDs use (in Japanese). In: Nishioka K, Nakamura H, editors. DMARDs use manual for the practice of medicine. Tokyo: Medical Pharmacological Journal; 2001. p. 117-34.
3. Lockie M, Smith DM. Forty-seven years experience with gold therapy in 1019 rheumatoid arthritis patients. Sem Arthritis Rheum 1985;14:238.
4. Baum J. Continuing look at penicillamine. J Rheumatol 1979;6:3-6.
5. Shinomiya. F, Okada M, Kanazawa K, Hamada Y, Ooishi T. Efficacy of auranofin administration for patients with early rheumatoid arthritis (in Japanese). Med Consult New Rem 1992;29: 1419-29.
6. Furst DE. Clinical pharmacology of combination DMARD therapy in rheumatoid arthritis. J Rheumatol 1996;23:86-90.
7. Lansbury J. Report of three-year study on the systematic and articular indexes in rheumatoid arthritis. Arthritis Rheum 1958;1: 505-22.
8. Fries CF. Reevaluating the therapeutic approach to rheumatoid arthritis: the sawtooth strategy. J Rheumatol 1990;17 Suppl:12-5.
9. Searle G, McKendry RJR. Methotrexate pneumonitis in rheumatoid arthritis. J Rheumatol 1987;14:1164-71.
10. Rosenthal M. Loss of efficacy of anti-rheumatic drugs in rheumatoid arthritis. J Rheumatol 1980;7:586-91.
11. Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, et al. Patients with rheumatoid arthritis benefit from early second-line therapy: 5-year follow up of a prospective double-blind placebo-controlled study. J Rheumatol 1995;22:2208-13.
12. Yamamoto S, Nakata S, Takubo N. Can DMARDs prevent articular destruction in RA? J Orthop Rheumatol 1996;9:52-7.
13. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
14. Sharp JT, Young DY, Gluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiological abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
15. Masi AT, Feigenbaum SL, Kaplan SB. Articular patterns in the early course of rheumatoid arthritis. Am J Med 1983;30:16-26.
16. Welsing PMJ,Gestel AM,Swinkels HL,Kiemeney LALM,Riel PLCM. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis. Rheum 2001;44:2009-17.
17. Ochi T, Iwase R, Yonemasu K, Matsukawa M, Yoneda M, Yukioka M, et al. Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:37-43.
18. Wilske KR, Healey LA. Remodeling the pyramid: a concept whose time has come. J Rheumatol 1989;19:565-7.
19. Wilske KR. Remodeling the therapeutic pyramid: evolving therapeutic strategies for rheumatoid arthritis. Jpn J Rheumatol 1999; 9:1-16.
20. Shinomiya F, Okada M, Kanazawa K, Ooishi T, Hamada Y, Araki M. Clinical courses and prognosis of multiple artificial joint replacement for patients with mutilating rheumatoid arthritis (in Japanese). Orthop Surg 1992;43:319-27.